Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 552,190,848
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 33,724 M
  • Annual Income, $ 12,151 M
  • 60-Month Beta 0.43
  • Price/Sales 16.51
  • Price/Cash Flow 42.91
  • Price/Book 37.47
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 26.90% ( -3.16%)
  • Historical Volatility 21.54%
  • IV Percentile 30%
  • IV Rank 19.71%
  • IV High 44.88% on 08/03/23
  • IV Low 22.48% on 06/13/23
  • Put/Call Vol Ratio 0.55
  • Today's Volume 31,064
  • Volume Avg (30-Day) 21,491
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 286,040
  • Open Int (30-Day) 269,645

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.82
  • Number of Estimates 2
  • High Estimate 0.82
  • Low Estimate 0.82
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +30.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.29 +1.45%
on 05/03/24
130.46 -5.68%
on 04/30/24
-3.94 (-3.10%)
since 04/03/24
3-Month
116.27 +5.83%
on 02/05/24
138.28 -11.01%
on 03/07/24
+9.35 (+8.22%)
since 02/02/24
52-Week
75.56 +62.85%
on 07/11/23
138.28 -11.01%
on 03/07/24
+39.17 (+46.69%)
since 05/03/23

Most Recent Stories

More News
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The anti-obesity medication stock is way up, and there could be more fuel in the tank.

NVO : 123.05 (-0.78%)
VKTX : 76.97 (+1.60%)
LLY : 734.97 (-2.77%)
Why Amgen Stock Zoomed Nearly 12% Higher Today

The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.

NVO : 123.05 (-0.78%)
LLY : 734.97 (-2.77%)
AMGN : 311.29 (+11.82%)
This Is a Huge Sigh of Relief for Novo Nordisk Investors

The path is clear for even more growth from Novo Nordisk's top two drugs, Ozempic and Wegovy.

LLY : 734.97 (-2.77%)
NVO : 123.05 (-0.78%)
Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript

NVO earnings call for the period ending March 31, 2024.

NVO : 123.05 (-0.78%)
Despite 350% Rally, Novo Trades at Discount to Eli Lilly

Novo Nordisk (NVO), known for its popular weight-loss drug Wegovy, has seen its shares surge by more than 350% since 2020, yet it continues to trade at a 30% discount to its main U.S. competitor, Eli Lilly...

NVO : 123.05 (-0.78%)
LLY : 734.97 (-2.77%)
Novo Nordisk: Q1 Earnings Snapshot

Novo Nordisk: Q1 Earnings Snapshot

NVO : 123.05 (-0.78%)
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.

We also look at the "treasure hunt" economy.

TSM : 141.56 (+3.91%)
WMT : 59.82 (+0.18%)
TGT : 158.04 (-0.05%)
DIS : 113.66 (+0.92%)
LLY : 734.97 (-2.77%)
AXP : 230.77 (-0.74%)
COF : 142.41 (+0.42%)
SPG : 142.93 (+1.11%)
NVO : 123.05 (-0.78%)
TJX : 95.11 (+0.21%)
DG : 137.49 (+0.25%)
ALLY : 39.37 (+1.47%)
Eli Lilly Raises Sales Forecast as Demand for Weight-Loss Drug Surges

Eli Lilly (LLY) has boosted its 2024 sales forecast by $2 billion, fueled by unprecedented demand for its innovative weight-loss drug, Zepbound, along with its diabetes treatment, Mounjaro. The surge in...

LLY : 734.97 (-2.77%)
TSLA : 181.19 (+0.66%)
WMT : 59.82 (+0.18%)
NVO : 123.05 (-0.78%)
Here's Why Novo Nordisk Stock Is a Buy Right Now

Novo Nordisk stock has surged, outperforming the market this year. Here's why it still looks like a buy right now.

NVO : 123.05 (-0.78%)
$SPX : 5,127.79 (+1.26%)
LLY : 734.97 (-2.77%)
Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks

The "Magnificent Seven" stocks dominate the artificial intelligence (AI) arena. One notable hedge fund manager has three in his top 10 holdings.

MSFT : 406.66 (+2.22%)
GOOGL : 167.24 (+0.37%)
TSLA : 181.19 (+0.66%)
INTC : 30.90 (+1.28%)
GOOG : 168.99 (+0.31%)
NVO : 123.05 (-0.78%)
NVDA : 887.89 (+3.46%)
META : 451.96 (+2.33%)
AMZN : 186.21 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 126.60
2nd Resistance Point 125.18
1st Resistance Point 124.12
Last Price 123.05
1st Support Level 121.64
2nd Support Level 120.22
3rd Support Level 119.16

See More

52-Week High 138.28
Last Price 123.05
Fibonacci 61.8% 114.32
Fibonacci 50% 106.92
Fibonacci 38.2% 99.52
52-Week Low 75.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar